Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, offering promising progress throughout different healthcare and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA supplies a safer, far more reliable substitute for therapeuti